(491 days)
Not Found
No
The description focuses on the device's operational modes based on pre-programmed parameters (time, temperature, impedance) and manual control, without mentioning any learning or adaptive capabilities characteristic of AI/ML. The "Mentions AI, DNN, or ML" section is also explicitly marked as "Not Found".
Yes.
The device is intended for the "ablation of tissue, including partial or complete ablation of non-resectable liver tumors," which directly treats a medical condition.
No
The device is intended for the ablation of tissue, specifically non-resectable liver tumors, which is a therapeutic rather than a diagnostic function. It delivers RF energy to heat and destroy tissue, not to identify or characterize disease.
No
The device description explicitly lists multiple hardware components including a generator, pump, electrodes, footswitch, and water container, indicating it is a hardware-based system with software control.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for "percutaneous, laparoscopic, and intraoperative coagulation and ablation of tissue, including partial or complete ablation of non-resectable liver tumors." This describes a therapeutic procedure performed on the patient's body, not a test performed on a sample taken from the body.
- Device Description: The description details a system that delivers RF energy directly to tissue within the patient's body to cause ablation. It involves electrodes placed in the tissue and a return electrode on the patient's skin. This is a direct intervention on the patient.
- Lack of IVD Characteristics: There is no mention of analyzing samples (blood, urine, tissue, etc.) or providing diagnostic information based on such analysis. The device's function is to physically alter tissue.
IVD devices are used to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. This device does not fit that description.
N/A
Intended Use / Indications for Use
The Cool-tip RF Ablation System E Series (generator, pump, patient return electrodes, water container, active electrodes, footswitch, and accessories) is intended for use in percutaneous, laparoscopic, and intraoperative coagulation and ablation of tissue, including partial or complete ablation of non-resectable liver tumors.
Product codes (comma separated list FDA assigned to the subject device)
GEI
Device Description
The Cool-tip™ RF Ablation System E Series (subject device) is a monopolar radio-frequency (RF) generator (RFAGEN) with dedicated components and accessories. The RFAGEN generator can be operated in one of several modes that use various combinations of time, tissue temperature, tissue impedance, and manual control. An interactive touchscreen display allows user input to the generator and displays informational signals and alert messages. Active electrodes are placed in the tissue to deliver RF energy to the tissue to be ablated. One, two, or three active electrodes can be attached to the generator and can be used individually or as multiple depending on electrode type and mode. A cluster electrodes assembled into one hub in a trianqular pattern can also be used. During the ablation of tissue, RF current flows from the generator to an active electrode which delivers the current to the patient. The RF current flows from the active electrode through the patient's body tissue to the return electrode, which recovers the current and returns it to the generator. The resistance to the current, provided by the patient's tissue, produces the heat that is necessary for ablation of tissue, including partial or complete ablation of non-resectable liver tumors.
A peristaltic pump circulates sterile cooling water from an I.V. bag, through active electrodes and into a wastewater container. Cooling water does not contact the patient and is not recirculated. The system does not provide fluids to or remove fluids from the patient.
The dedicated system components include:
- o RF Generator (RFAGEN), radio frequency generator
- RF Ablation Pump (RFAPUMP), peristaltic pump for circulating cooling water ●
- . RF Ablation Connector Bank (RFACB) cable for connecting return electrodes to the generator
- Ablation Foot Switch (RFASW), generator footswitch ●
- Ablation Water Container (RFAWC), wastewater collection container ●
The RFAGEN generator is packaged individually and is always supplied with the accessory kit RFAPAC (separately packaged) which contains items RFAPUMP, RFACB, RFASW, and RFAWC.
The following Cool-tip™ RF Ablation System E Series compatible accessories are single use:
- RF Ablation Single Electrode Kits E Series (RFAXXX), RF Ablation Multiple Electrode ● Kits E Series (RFAXXXX), and RF Ablation Cluster Electrode Kits E Series (RFACXXXX)
- RF Ablation Patient Return Electrode E Series (RFAPAD) ●
- Ablation Remote Temperature Probe (RTP20) (optional) ●
The Cool-tip™ RF Ablation System E Series can be mounted on an optional system cart FT900RFA with the FT3X cart kit that has locations for each system component.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
tissue, liver tumors
Indicated Patient Age Range
Not Found
Intended User / Care Setting
percutaneous, laparoscopic, and intraoperative
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-clinical performance testing was performed, and reports are provided in support of substantial equivalence with the predicate device.
9.1 Summary of Bench Testing
Electrical Safety and Electromagnetic Compatibility (EMC):
Bench testing and verification were conducted to ensure proper device function. At the system level, electrical safety and electromagnetic compatibility were evaluated to establish conformity to the applicable IEC 60601 safety standards.
The performance and safety of the Cool-tip™ RF Ablation System E Series was characterized using laboratory (bench) verification and simulated-use validation testing of soft tissue performance providing a characterization of the E Series system ablation performance across the complete range of modes, electrodes, and in three tissue types: liver, kidney, and muscle. Ablation performance verifying the equivalence between the predicate Cool-tip™ RFA System and the Cooltip™ RF Ablation System E Series when used with the Cool-tip™ RF Ablation Electrode Kits E Series was performed at the system and sub-system level to demonstrate the following:
- o Cool-tip™ E Series RF Ablation Generator meets all design and performance requirements necessary to prove substantial equivalence with the predicate device,
- Cool-tip™ E Series RF Ablation Generator meets all ablation performance design requirements and to demonstrate the ablations zone dimensions created with the Cool-tip™ E Series Ablation Generator (subject) and Cool-tip™ RF Ablation Generator (predicate) are equivalent.
- . The previously cleared accessories (remote temperature probe and footswitch) are compatible with the Cool-tip™ E Series Ablation Generator (RFAGEN),
- The RF Ablation Patient Return Electrode E Series (RFAPAD), peristaltic pump (RFAPUMP), ● and RF Ablation Connector Bank (RFACB) cable meet design and performance requirements,
- The Cool-tip™ RF Ablation System E Series with Ablation Generator meets IEC, EMC, regulatory and safety requirements,
- The Cool-tip™ E Series RF Ablation System E and optional Cart (FT900RFA) performs as . specified within specified storage and use conditions,
- Validate the usability of Cool-tip™ RF Ablation System E Series Ablation Generator ● (RFAGEN) with the intended users,
- The Cool-tip™ E Series RF Ablation Generator (RFAGEN), Patient Return Electrode (RFAPAD), RF Ablation Single Electrode Kits E Series (RFAXXXX), RF Ablation Multiple Electrode Kits E Series (RFAXXXXX), and RF Ablation Cluster Electrode Kits E Series (RFACXXX), and Cart (FT900RFA) packaging can provide protection during simulated transportation.
9.2 Animal Testing
In-vivo testing conducted demonstrated the histological, thermal and ablative performance, as well as procedural safety of the subject device is equivalent to the predicate for the Cool-tip™ E Series intended use.
9.3 Clinical Testing
Clinical studies in human subjects were not required to demonstrate the performance and safety of the Cool-tip™ RF Ablation System E Series generator and accessories.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 878.4400 Electrosurgical cutting and coagulation device and accessories.
(a)
Identification. An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current.(b)
Classification. Class II.
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the symbol of the Department of Health and Human Services on the left and the FDA acronym followed by the full name of the agency on the right. The FDA acronym is in blue, and the full name is in a slightly lighter shade of blue. The logo is simple and professional, reflecting the agency's mission to protect public health.
February 25, 2022
Covidien LLC Liron Bar vaakov Senior Manager, Regulatory Affairs 5920 Longbow Drive Boulder, Colorado 80301
Re: K203150
Trade/Device Name: Cool-tip RF Ablation System E Series Regulation Number: 21 CFR 878.4400 Regulation Name: Electrosurgical Cutting and Coagulation Device and Accessories Regulatory Class: Class II Product Code: GEI Dated: January 19, 2022 Received: January 21, 2020
Dear Liron Yaakov:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpm/pmn.cfm identifies.combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801; medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE(@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Long Chen, Ph.D. Assistant Director DHT4A: Division of General Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K203150
Device Name Cool-tip RF Ablation system E Series
Indications for Use (Describe)
The Cool-tip RF Ablation System E Series (generator, pump, patient return electrodes, water container, active electrodes, footswitch, and accessories) is intended for use in percutaneous, laparoscopic, and intraoperative coagulation and ablation of tissue, including partial or complete ablation of non-resectable liver tumors.
| Type of Use (Select one or both, as applicable) |
|---|
| ------------------------------------------------- |
| ☒ Prescription Use (Part 21 CFR 801 Subpart D) |
|---|
| □ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary
1. Date of Summary Preparation
February 24, 2022
2. 510(k) Submitter/Holder
Covidien IIc
5920 Longbow Drive
Boulder, CO. 80301
3. Contact: Liron Bar Yaakov
Senior Manager, Regulatory Affairs (303) 581-6668
Email: liron.baryaakov@medtronic.com
Address: 5920 Longbow Drive
Boulder, CO. 80301
4. Device
| Device Trade Name: | Cool-tip™ RF Ablation System E Series |
|---|---|
| Device Common Name: | RF Ablation System |
| Classification Name: | Electrosurgical Cutting and Coagulation Device and Accessories |
| Regulation: | 21 CFR 878.4400 |
| Regulatory Class: | II |
| Product Code: | GEI |
5. Predicate Device
The Cool-tip™ RF Ablation System E Series is substantially equivalent to the following, commercially available predicate devices:
| Device Name | Classification Name and Class | 510(k) Number(s) |
|---|---|---|
| Cool-tip™ RF Ablation | ||
| Generator | Electrosurgical, Cutting & Coagulation & Accessories | K052796 |
| (Primary Predicate Device) | ||
| Cool-tip™ Switching | ||
| Controller | Electrosurgical, Cutting & Coagulation & Accessories | K070446 |
6 Intended Use / Indications for Use
The Covidien Cool-tip™ RF Ablation System E Series (generator, pump, patient return electrodes, water container, active electrodes, footswitch, and accessories) is intended for use in percutaneous, laparoscopic, and intraoperative coagulation and ablation of tissue, including partial or complete ablation of non-resectable liver tumors.
4
6.1 Indication Difference from the Predicate Device
The indication of "osteoid osteoma tumors within bone" has been removed from the subject device.
This change is not critical to the intended therapeutic, prosthetic or surgical use of this device and does not affect the safety and effectiveness of the device when used as labeled.
7. Device Description
The Cool-tip™ RF Ablation System E Series (subject device) is a monopolar radio-frequency (RF) generator (RFAGEN) with dedicated components and accessories. The RFAGEN generator can be operated in one of several modes that use various combinations of time, tissue temperature, tissue impedance, and manual control. An interactive touchscreen display allows user input to the generator and displays informational signals and alert messages. Active electrodes are placed in the tissue to deliver RF energy to the tissue to be ablated. One, two, or three active electrodes can be attached to the generator and can be used individually or as multiple depending on electrode type and mode. A cluster electrodes assembled into one hub in a trianqular pattern can also be used. During the ablation of tissue, RF current flows from the generator to an active electrode which delivers the current to the patient. The RF current flows from the active electrode through the patient's body tissue to the return electrode, which recovers the current and returns it to the generator. The resistance to the current, provided by the patient's tissue, produces the heat that is necessary for ablation of tissue, including partial or complete ablation of non-resectable liver tumors.
A peristaltic pump circulates sterile cooling water from an I.V. bag, through active electrodes and into a wastewater container. Cooling water does not contact the patient and is not recirculated. The system does not provide fluids to or remove fluids from the patient.
The dedicated system components include:
- o RF Generator (RFAGEN), radio frequency generator
- RF Ablation Pump (RFAPUMP), peristaltic pump for circulating cooling water ●
- . RF Ablation Connector Bank (RFACB) cable for connecting return electrodes to the generator
- Ablation Foot Switch (RFASW), generator footswitch ●
- Ablation Water Container (RFAWC), wastewater collection container ●
The RFAGEN generator is packaged individually and is always supplied with the accessory kit RFAPAC (separately packaged) which contains items RFAPUMP, RFACB, RFASW, and RFAWC.
The following Cool-tip™ RF Ablation System E Series compatible accessories are single use:
- RF Ablation Single Electrode Kits E Series (RFAXXX), RF Ablation Multiple Electrode ● Kits E Series (RFAXXXX), and RF Ablation Cluster Electrode Kits E Series (RFACXXXX)
- RF Ablation Patient Return Electrode E Series (RFAPAD) ●
- Ablation Remote Temperature Probe (RTP20) (optional) ●
The Cool-tip™ RF Ablation System E Series can be mounted on an optional system cart FT900RFA with the FT3X cart kit that has locations for each system component.
8. Comparison of Technological Characteristics with the Predicate Device
The Cool-tip™ RF Ablation System E Series (subject device) relies on the same principles of operation and has similar performance characteristics, with respect to its intended use, as the predicate devices. The Cool-tip™ RF Ablation System E Series combines the functional characteristics of the predicate Cool-tip™ generator (K052796) and the Cool-tip™ Switching Controller (K070446).
5
There are three main differences between the Cool-tip™ RF Ablation System E Series and the predicate Cool-tip™ RF Ablation System
-
- A new larger patient return electrode (RFAPAD) allowing for two return electrodes for ablations where four electrodes are required for the predicate device. The return electrode connector bank (RFACB) is a new dedicated reusable extension cable that connects the patient return electrodes to the generator.
-
- The RFAGEN generator combines the functional characteristics of both the predicate Cooltip™ generator and the Cool-tip™ Switching Controller into a single RF generator that includes an updated user interface and software controls.
-
- The addition of several optional accessories, specifically, a footswitch, remote temperature probe and system cart.
Like the predicate device, the Cool-tip™ RF Ablation E Series System has three categories of Cooltip ™ RF Ablation electrodes. The categories are single, multiple and cluster electrodes. The Cooltip™ E Series active electrodes deliver RF energy from the Cool-tip™ E Series generator for the ablation of tissue when used with the Cool-tip™ E Series Pump, Inflow and Outflow Tubing Sets, and RFAPAD Patient Return Electrodes. All Cool-tip™ RF Ablation E Series are provided in kits containing sterile active electrodes, sterile tubing for electrode cooling fluid, and patient return electrodes. Electrode Kits with single, multiple and cluster active electrodes are available. All kit items are single use.
9. Performance Testing
Non-clinical performance testing was performed, and reports are provided in support of substantial equivalence with the predicate device.
9.1 Summary of Bench Testing
Electrical Safety and Electromagnetic Compatibility (EMC):
Bench testing and verification were conducted to ensure proper device function. At the system level, electrical safety and electromagnetic compatibility were evaluated to establish conformity to the applicable IEC 60601 safety standards, as identified below.
- IEC 60601-1:2005/AMD1:2012 Medical Electrical Equipment Part 1 General Requirements for Basic Safety and Essential Performance
- . IEC 60601-1-2:2014 (4th Edition) Medical Electrical Equipment - Part 1-2: General Requirements for Basic Safety and Essential Performance - Collateral Standard: Electromagnetic Disturbances - Requirements and Tests
- IEC 60601-1-6:2010, AMD1:2013 General Requirements for Basic Safety and Essential ● Performance Safety - Collateral Standard: Usability
- . IEC 60601-2-2:2017 Medical Electrical Equipment Part 2-2: Particular Requirements for the Basic Safety and Essential Performance of High Frequency Surgical Equipment and High Frequency Surgical Accessories
The performance and safety of the Cool-tip™ RF Ablation System E Series was characterized using laboratory (bench) verification and simulated-use validation testing of soft tissue performance providing a characterization of the E Series system ablation performance across the complete range of modes, electrodes, and in three tissue types: liver, kidney, and muscle. Ablation performance verifying the equivalence between the predicate Cool-tip™ RFA System and the Cooltip™ RF Ablation System E Series when used with the Cool-tip™ RF Ablation Electrode Kits E Series was performed at the system and sub-system level to demonstrate the following:
6
- o Cool-tip™ E Series RF Ablation Generator meets all design and performance requirements necessary to prove substantial equivalence with the predicate device,
- Cool-tip™ E Series RF Ablation Generator meets all ablation performance design requirements and to demonstrate the ablations zone dimensions created with the Cool-tip™ E Series Ablation Generator (subject) and Cool-tip™ RF Ablation Generator (predicate) are equivalent.
- . The previously cleared accessories (remote temperature probe and footswitch) are compatible with the Cool-tip™ E Series Ablation Generator (RFAGEN),
- The RF Ablation Patient Return Electrode E Series (RFAPAD), peristaltic pump (RFAPUMP), ● and RF Ablation Connector Bank (RFACB) cable meet design and performance requirements,
- The Cool-tip™ RF Ablation System E Series with Ablation Generator meets IEC, EMC, regulatory and safety requirements,
- The Cool-tip™ E Series RF Ablation System E and optional Cart (FT900RFA) performs as . specified within specified storage and use conditions,
- Validate the usability of Cool-tip™ RF Ablation System E Series Ablation Generator ● (RFAGEN) with the intended users,
- The Cool-tip™ E Series RF Ablation Generator (RFAGEN), Patient Return Electrode (RFAPAD), RF Ablation Single Electrode Kits E Series (RFAXXXX), RF Ablation Multiple Electrode Kits E Series (RFAXXXXX), and RF Ablation Cluster Electrode Kits E Series (RFACXXX), and Cart (FT900RFA) packaging can provide protection during simulated transportation.
9.2 Animal Testing
In-vivo testing conducted demonstrated the histological, thermal and ablative performance , as well as procedural safety of the subject device is equivalent to the predicate for the Cool-tip™ E Series intended use.
9.3 Clinical Testing
Clinical studies in human subjects were not required to demonstrate the performance and safety of the Cool-tip™ RF Ablation System E Series generator and accessories.
10. Software
Software for the Cool-tip™ RF Ablation System E Series was developed in accordance with IEC 62304 Medical device software life-cycle practices and FDA Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices with a Major Level of Concern. System level software testing was completed successfully (SW version1.41.01).
11. Biocompatibility
The direct patient contacting devices of the Cool-tip™ RF Ablation System E Series are the patient return electrode, active electrode and remote temperature probe. These devices are disposable and intended for single use. These devices were assessed for biocompatibility and potential adverse health effects associated with patient contacting disposable devices and were determined to be acceptable.
7
Direct Patient Contacting Devices;
Patient Return Electrode (RFAPAD):
The RFAPAD is used to collect the RF energy delivered at the active electrode and return it to the qenerator.
The patient contacting materials in the RFAPAD patient return electrode were tested to the biocompatibility requirements shown below.
- Cytotoxicity
- Sensitization ●
- Irritation or Intracutaneous Reactivity
- Materials Mediated Pyrogenicity ●
Active Electrode:
Active electrodes are placed in the tissue to deliver RF energy to the tissue being ablated.
The patient contacting materials in the Active Electrode were tested to the biocompatibility requirements shown below:
- Cytotoxicity Test
- Sensitization Test
- Intracutaneous Irritation Test ●
- Acute Systemic Toxicity Test ●
- Materials Mediated Pyrogenicity ●
Remote Temperature Probe (RTP20):
The RTP20 is an optional single use sterile device used to determine the temperature of tissue near the treatment site.
The patient contacting materials in the Remote Temperature Probe were tested to the biocompatibility requirements shown below.
- Cytotoxicity Test ●
- Sensitization Test ●
- Intracutaneous Irritation Test
- Acute Systemic Toxicity Test ●
- Materials Mediated Pvrogenicity Test
12. Sterilization and Shelf life
The active electrode and optional remote temperature provided sterile with EtO with SAL of 10°, are intended for use within the sterile field, and are designed for single use only.
Active Electrode and Inflow and Outflow Tubing:
The sterile active electrodes and inflow/outflow tubing are identical to the previously cleared devices (K052796, K070446). The Cool-tip™ RF Ablation System E Series electrodes, inflow and outflow tubing sets are packaged together and sterilized with EtO to a sterility level of 10-9. The sterile packaging is labeled as sterile for five years immediately following the date of packaging.
The single use patient return electrode are not provided sterile and have a shelf life of three (3) years.
Remote Temperature Probe:
The RTP20 used on the Cool-tip™ RF Ablation System E Series is identical to the device previously cleared with the Emprint Ablation System (K133821). The RTP20 is a sterile single use device, sterilized with EtO to a sterility level of 10-6, and labeled with three (3) years shelf life.
8
13. Conclusion
The Cool-tip™ RF Ablation System E Series (subject device) and Cool-tip™ RF Ablation System (predicate device) have equivalent power and ablation performance characteristics based on verification and validation testing, and pre-clinical studies. Verification testing of the optional accessories consisting of the system cart, the footswitch, and remote temperature probe was conducted for their use with the subject device. As a result, the Cool-tip™ RF Ablation System E Series has been shown to be substantially equivalent to the predicate device and does not raise different questions of safety and effectiveness.